Name

Celprogen

Legal name

Celprogen Inc.

Website

https://celprogen.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Stem Cell Research Products

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industries

Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ), Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS) (EUAAAIAC)

Keywords

• Stem cell research
• Cancer stem cells
• Extracellular matrix
• 3D cell culture
• Regenerative medicine

Headquarters

HQ city

Torrance

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Research Products (Life Science): Sale of biological products including stem cells (human, mouse, rat), cancer stem cells, iPCs, extracellular matrices, tissue culture media, growth factors, cDNA, RNA, enzymes, reagents, cell lines, and assay kits. Products are sold through e-commerce storefront with pricing ranging from under $100 for small reagents to over $10,000 for large-scale products like conditioned media batches.
2. Cosmetic Ingredients and Products: Sale of stem cell conditioned media, plant and marine stem cell extracts, and cosmetic products (FolliStem hair growth, Jawan serum, ADIOStem) to cosmetic and personal care manufacturers and consumers.
3. Medical Devices: Sale of laboratory devices including micro-incubators, microscope slide chambers (4, 8, 10, 18-well formats), and the CPG 2000 Microplate Reader & Spectrophotometer for research and in vitro diagnostics industries.
4. Custom Services and Contract Manufacturing: Fee-for-service offerings including custom cell line development, stable cell line creation, custom media formulation, conditioned media production (1L to 10,000L batches), and aseptic filling services (5ml to 500ml fill volumes). Drug discovery services include IC50 generation, in-vitro/in-vivo screening in 3D culture and PDX models, and pathway analysis.
5. Therapeutic Development: Development of pharmaceutical agents and drugs in cardiovascular, diabetes, neurological, renal, and metabolic disorders through the Therapeutics division. Revenue model may include licensing, milestone payments, or co-development arrangements with pharmaceutical partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Celprogen is a biotechnology company that develops, manufactures, and sells life-science research products — including stem cells, cancer stem cells, tissue-specific extracellular matrices, primary and cancer cell lines, cell culture media, reagents, and cell-based ELISA assay kits — alongside medical devices such as micro-incubators and microscope slide chambers, 3D-printed organ scaffolds (heart, pancreas), COVID-19 RT-PCR diagnostic kits, patient-derived xenograft (PDX) models, custom cell line development and media formulation services, therapeutics, and stem-cell-derived cosmetic products including FolliStem, Jawan, and ADIOStem.

Differentiator

Problem solved

Functional benefit

Brands

• FolliStem: Hair growth stimulating product derived from adipose stem cells
• Jawan
• ADIOStem

Products and services

• Stem Cells and Primary Cell Lines Tissue-derived primary cells and stem cell lines supplied for academic and biotech research applications in cell biology, developmental biology, and regenerative medicine studies.
• Cancer Stem Cells (CSCs) Isolated and characterized cancer stem cell lines sold to researchers studying tumor initiation, drug resistance, and oncology drug discovery.
• Tissue-Specific Extracellular Matrix (ECM) Products Proprietary tissue-specific ECM coatings, gels, and scaffolds used to support 3D cell culture, stem cell expansion, and tissue-mimetic in vitro models for academic and industry researchers.
• Cell Culture Media and Reagents Standard and custom cell culture media, supplements, and reagents for maintaining and differentiating primary cells, stem cells, cancer cell lines, and 3D cultures.
• Cell-Based Assay ELISA Kits Ready-to-use cell-based ELISA assay kits for quantifying cellular responses, biomarkers, and signaling in research and drug discovery workflows.
• 3D-Printed Organ Scaffolds (Heart and Pancreas) 3D-bioprinted organ scaffolds for heart and pancreas used in regenerative medicine research, tissue engineering, and in vitro organ-model development.
• Patient-Derived Xenograft (PDX) Models Patient-derived xenograft tumor models and related services for preclinical oncology research and drug evaluation studies.
• COVID-19 RT-PCR Test Kit Molecular diagnostic RT-PCR assay kit for detection of SARS-CoV-2, sold to research and diagnostic laboratories.
• Medical Devices (Micro-Incubator, Microscope Slide Chambers, Microplate Reader) Specialized laboratory instruments including a micro-incubator for live-cell imaging, microscope slide chambers, and a microplate reader, sold to research and clinical labs.
• Stem Cell-Derived Cosmetic Products (FolliStem, Jawan, ADIOStem) Branded stem cell-derived cosmetic and personal care products sold to consumers and offered as OEM/private-label SKUs to cosmetic brand buyers and skincare clinics.
• Custom Cell Line Development and Custom Media Formulation Services Custom development of cell lines and custom cell culture media formulations delivered to biotech, pharma, and academic clients as fee-for-service projects.
• Therapeutics Division Programs Therapeutic candidates and programs developed through Celprogen's regenerative medicine platform, distinct from the research products catalog and targeted at clinical/therapeutic applications.

Quantifiable outcome

• Products have been cited in scientific publications (e.g., 24 citations for Human Microglia Primary Cell Culture ECM, 17 citations for Human Astrocyte Cell Culture ECM, 11 citations for Human Pancreatic Cancer Stem Cell, Bioz Stars ratings of 90-94/100 indicating high product quality)

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• STEMCELL Technologies: Largest pure-play stem cell research tools company, offering a comparable portfolio of stem cells, media, culture systems, and assay kits. Direct competitor in nearly every product category Celprogen serves.
• ATCC: Global biological resource center providing authenticated cell lines, cancer cell lines, primary cells, and related reagents. Directly comparable to Celprogen's life science catalog and serves overlapping academic/biotech customers.
• Bio-Techne: Developer and manufacturer of purified proteins (cytokines, growth factors), ELISA kits, and cell culture reagents including the R&D Systems brand. Overlaps directly with Celprogen's growth factors, assay kits, and stem cell media.
• PromoCell: Specializes in primary human cells, stem cells, and optimized cell culture media. Direct competitor in the primary cell culture and stem cell research tools niche.
• Miltenyi Biotec: Developer of cell separation technologies, stem cell products, and cell-based assays. Overlaps with Celprogen's stem cell catalog, cell-based ELISA kits, and regenerative medicine focus.

Broad incumbents

• Corning Life Sciences: Major manufacturer of cell culture vessels, extracellular matrices (Matrigel/Matrigel alternatives), and 3D culture systems (Corning Matrigel, spheroid microplates). Comparable ECM and 3D culture offerings to Celprogen but as part of a much broader portfolio.
• Lonza: Global CDMO and cell therapy manufacturer offering cell culture media, primary cells, and stem cell products. Overlaps with Celprogen's custom media and contract manufacturing services at much larger scale.
• Thermo Fisher Scientific: Largest life science tools company with overlapping offerings in cell culture media (Gibco), cell lines, reagents, and molecular diagnostics. Competes across nearly every product line Celprogen offers.
• MilliporeSigma (Sigma-Aldrich/Merck KGaA): Major supplier of cell culture media, reagents, and molecular biology products. Comparable to Celprogen's reagents, tissue culture media, and molecular biology offerings as part of a much larger portfolio.

Emerging players

• Organovo: Pioneer in 3D bioprinting of human tissues for research and therapeutic applications. Comparable to Celprogen's 3D-printed organ scaffold technology in heart and pancreas, though focused on different tissue types.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/celprogeninc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celprogen